Biodesix, Inc., a fully integrated molecular diagnostics company dedicated to personalizing medicine, today announced that Vice President of Business Development and Strategic Marketing, Paul Beresford, Ph.D., will present at the 2013 World CDx Summit taking place in Boston, November 12-15, 2013. Dr. Beresford will discuss the benefits of proteomics in diagnostic test discovery and how when paired with MALDI-ToF mass spectrometry (MALDI) and analytical analysis, diagnostic tests can be developed quickly and more precisely to focus on a target clinical question.
Help employers find you! Check out all the jobs and post your resume.
